Skip to content

TTRX TTRX Change in Other Assets

Change in Other Assets at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$27M-41.3%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$88K+111%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$6.28M-239%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$11.73M+257%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$3.57M+228%
PVL
Palvella TherapeuticsPVLA
$357K+144%

Other financials

Income statement

See full
Operating income-$1.2M-224%
Net income-$971.0K-196%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$11.2M+613%
Total debt$6.0M
Total equity$6.1M+647%
Total assets$18.6M

Cash flow

See full
Operating cash flow-$1.6M-448%

Valuation

See full
Market cap$217.45M-17.7%
Enterprise value$212.24M

Returns & leverage

See full
Return on equity-118.8%
Debt / equity
Current ratio2.2×

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TTRX's change in other assets?
TTRX (TTRX) reported change in other assets of $123.74K in Q1 2026.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.